Elsevier Stem Cell

Curious about #OpenAccess? Our new #ElsevierExplainers video breaks it all down for you. Learn the basics of open access publishing in just two minutes. spkl.io/6018fTO5M

Our systems will guide you through #OpenAccess publishing and we employ ‘price logic’ to ensure you get the best price for your chosen journal. Learn more: spkl.io/6019fraYP #Together4OpenScience

Our Geographical Pricing for #OpenAccess pilot includes a subset of our fully open access journals, which waive or discount their APC based on the local economic conditions and average income of the corresponding author’s country. Learn more: spkl.io/6014fRUhQ

Authors from institutions worldwide can publish #OpenAccess through read and publish agreements with us, which means publishing in one of our journals is often as simple as confirming your affiliation during submission. Learn more: spkl.io/6010fRUAm #Together4OpenScience

If you’re eligible for #Research4Life, the article publishing charge (APC) waiver/discount is automatically applied when you submit your paper to a fully open access journal. Learn more: spkl.io/6011fRw0U #OAsupport #OApublishing #Together4OpenScience

We work with the research community to develop flexible and inclusive #OpenAccess options for our authors. Read how we are making publishing OA accessible for authors around the world: spkl.io/6018fRwaY #OAsupport #OApublishing #Together4OpenScience

Discover a quality #OpenAccess journal for your research with Elsevier! We’ll support you every step of the way to help you publish the best work possible. Learn more: spkl.io/6018fR69C #Qualityjournals #Together4OpenScience

🌏We are committed to fostering a more inclusive and diverse research ecosystem. Our Find Reviewers tool, powered by #AI and #Machinelearning, is helping editors identify the best and most diverse voices in science. 👉 Find out how in our latest blog spkl.io/6014fzNnG

🤔 "Am I ready to review someone else’s research?" This question is common among early career researchers (ECRs) as they step into peer review for the first time. 👇Discover how 2️⃣ Early career researchers navigated peer reviewing in our latest blog spkl.io/6014fzNys

🔍Editors can sift through more than 17M authors to find the best and most relevant reviewers ✨New reviewers get more exposure 👉 spkl.io/6010fJLrM Discover how the Find Reviewer Tool transforms #PeerReview by expanding and diversifying the reviewer pool! #PeerReviewWeek

🦾When beginning peer reviewing, it's normal to feel unprepared. Remember, your unique perspective adds value to research. This #PeerReviewWeek read the experiences of 2️⃣ early career researchers @MohdAlsharid and @pernischova in navigating #PeerReview spkl.io/6012fJqbn

🤔What does an editor look for in a review? "Thoughtful and constructive feedback always offer valuable insights", says @MMOrosun Muyiwa Orosun, Associate editor @HeliyonJournal Learn to review effectively through our free Certified #PeerReview course. spkl.io/6016fJiQo

Advances in Cancer Biology – Metastasis is still seeking section editors in Cancer Cell Metabolism and Tumor Microenvironment. This is your chance to join the growing open access journal and elevate your career in research. Learn more! spkl.io/60164fHs2

Is your area of expertise Cancer Cell Metabolism or Tumor Microenvironment and did you always want to work on an open access journal? This is your chance! Advances in Cancer Biology – Metastasis is seeking Section Editors to join the team. Apply now! spkl.io/60144fHqu

⚠️ Last chance ❗ The free webinar on CRISPR-based Cell Therapy: Advancements in CRISPR Technology and its application in treating Hematologic Diseases will start in just over an hour. Tune in live and hear the latest from Prof. Ying Zhang. spkl.io/601744tBv

CRISPR-based Cell Therapy: Advancements in CRISPR Technology and its application in treating Hematologic Diseases Cell Insight invites you to hear the latest from Prof. Ying Zhang. Learn more about CRISPR by joining the live event tomorrow at 2PM CEST ⬇️ spkl.io/601944t8b

Cell Insight invites you to the free live webinar: CRISPR-based Cell Therapy: Advancements in CRISPR Technology and its application in treating Hematologic Diseases on June 7th at 14:00 CEST. Mark you agenda and join us next week! 🔬 spkl.io/601544tDV

⭐Amazing opportunity ⭐ Advances in Cancer Biology – Metastasis is seeking Section Editors. Take your career in research to the next level and join our team! Find out more 👇 spkl.io/60164fHUe

Are you interested to learn more about CRISPR-based Cell Therapy? Hear about advancements in CRISPR Technology and its application in treating Hematologic Diseases in our live webinar on June 7th at 14:00 CEST. Join for free! spkl.io/601944t1U

CRISPR-based Cell Therapy: Advancements in CRISPR Technology and its application in treating Hematologic Diseases 🧬 Join our upcoming Live Webinar on June 7th at 14:00 CEST. Find out more on the link below: 👇 spkl.io/601744t6W